Rtw Investments »

Avalo Therapeutics Ord shares owned by Rtw Investments

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Rtw Investments from 13F filings

Historical chart of Rtw Investments investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Rtw Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Rtw Investments

Quarter filed Position value Share count Share price at filing
2026-03-31 $13M 857k 14.93

More positions owned by Rtw Investments

Madrigal Pharmaceuticals (MDGL)
Insmed Com Par $.01 (INSM)
Protagonist Therapeutics (PTGX)
Ptc Therapeutics I (PTCT)
Argenx Se Sponsored Adr (ARGX)
Cg Oncology (CGON)
Celcuity (CELC)
Tango Therapeutics (TNGX)
Erasca (ERAS)
Natera (NTRA)
RadNet (RDNT)
Tarsus Pharmaceuticals (TARS)
Apogee Therapeutics (APGE)
Spyre Therapeutics Com New (SYRE)
Cogent Biosciences (COGT)

View all positions for Rtw Investments

Top funds holding Avalo Therapeutics Ord

FMR
Caligan Partners
BVF
venBio Select Advisor
Affinity Asset Advisors
Logos Global Management
Nantahala Capital Management
UBS Group
Caption Management
Point72 Asset Management
Farallon Capital Management
Rtw Investments
Adage Capital Partners GP
Millennium Management
Vanguard Group

View all funds holding Avalo Therapeutics Ord